| Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis (NCT03575871) | Pfizer | 2018-06-29 |
| 4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes (NCT03538743) | Pfizer | 2018-06-25 |
| Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors (NCT03565991) | Pfizer | 2018-06-18 |
| Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia. (NCT03794609) | Pfizer | 2018-06-15 |
| Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects (NCT03627767) | Pfizer | 2018-06-11 |
| Xeljanz Special Investigation for Long-term Use in UC Patients (NCT03643211) | Pfizer | 2018-06-08 |
| Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031 (NCT03573882) | Pfizer | 2018-06-06 |
| A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults (NCT03572062) | Pfizer | 2018-06-05 |
| Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants (NCT03550313) | Pfizer | 2018-06-01 |
| Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In India (NCT03548337) | Pfizer | 2018-05-31 |
| PF-06741086 Long-term Treatment in Severe Hemophilia (NCT03363321) | Pfizer | 2018-05-30 |
| Glasdegib Renal Impairment Study (NCT03596567) | Pfizer | 2018-05-17 |
| A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma (NCT03530683) | Pfizer | 2018-05-14 |
| A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA (NCT03000439) | Pfizer | 2018-05-10 |
| Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation (NCT03570047) | Pfizer | 2018-05-08 |
| A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF) (NCT03472560) | Pfizer | 2018-05-02 |
| A Single Dose Crossover Study In Healthy Subjects To Evaluate Different Formulations Of PF-06882961 (NCT03492697) | Pfizer | 2018-04-30 |
| A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD (NCT03539601) | Pfizer | 2018-04-27 |
| Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis (NCT03469336) | Pfizer | 2018-04-24 |
| A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia (NCT03416179) | Pfizer | 2018-04-20 |
| "Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC" (NCT03538717) | Pfizer | 2018-04-19 |
| Evaluation of Pharmacokinetic Drug Drug Interaction Between PF-05221304 And PF-06865571 In Healthy Adult Subjects (NCT03534648) | Pfizer | 2018-04-19 |
| A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults (NCT03529773) | Pfizer | 2018-04-18 |
| Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects (NCT03448172) | Pfizer | 2018-04-18 |
| A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma (NCT03460977) | Pfizer | 2018-04-17 |
| A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation (NCT03439514) | Pfizer | 2018-04-17 |
| Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants (NCT03512288) | Pfizer | 2018-04-16 |
| A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. (NCT03329092) | Pfizer | 2018-04-05 |
| Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis (NCT03422822) | Pfizer | 2018-03-08 |
| A Study of PF-06873600 in People With Cancer (NCT03519178) | Pfizer | 2018-03-07 |
| TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING. (NCT04498481) | Pfizer | 2018-03-01 |
| Trial in Adult Subjects With Acute Migraines (NCT03461757) | Pfizer | 2018-02-27 |
| Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease (NCT03801928) | Pfizer | 2018-02-23 |
| Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE® (NCT03445637) | Pfizer | 2018-02-08 |
| Sedation Of Adult Patients Undergoing Gastrointestinal Endoscopy: A Network Meta-analysis (NCT03632330) | Pfizer | 2018-02-05 |
| Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease (NCT03395184) | Pfizer | 2018-02-02 |
| Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea (NCT03572972) | Pfizer | 2018-01-31 |
| A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy (NCT03362502) | Pfizer | 2018-01-23 |
| A Study In Adults With Moderate To Severe Dermatomyositis (NCT03181893) | Pfizer | 2018-01-23 |
| Study Of Safety, Tolerability And Pharmacokinetics Of Subcutaneous Doses Of TA-46 (NCT04410809) | Pfizer | 2018-01-19 |
| A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects (NCT03372044) | Pfizer | 2018-01-19 |
| A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis (NCT03356977) | Pfizer | 2018-01-16 |
| Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors (NCT03864042) | Pfizer | 2018-01-02 |
| Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies (NCT03317496) | Pfizer | 2017-12-21 |
| Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United States (NCT03353480) | Pfizer | 2017-12-20 |
| Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment (NCT03309202) | Pfizer | 2017-12-19 |
| Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC (NCT03395197) | Pfizer | 2017-12-18 |
| Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis (NCT03349060) | Pfizer | 2017-12-07 |
| A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors (NCT03343054) | Pfizer | 2017-11-30 |
| Immunization To Prevent Acute COPD Exacerbations (NCT03276754) | Pfizer | 2017-11-30 |
| PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma (NCT03269136) | Pfizer | 2017-11-29 |
| Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis (NCT03334851) | Pfizer | 2017-11-17 |
| A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission (NCT03281304) | Pfizer | 2017-11-16 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects (NCT03351751) | Pfizer | 2017-11-08 |
| Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies (NCT03031938) | Pfizer | 2017-11-03 |
| Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis (NCT03387423) | Pfizer | 2017-11-02 |
| PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors (NCT03284723) | Pfizer | 2017-11-01 |
| A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers (NCT03273842) | Pfizer | 2017-10-27 |
| Safety and Efficacy of Xalkori ROS1 (NCT03375242) | Pfizer | 2017-10-25 |
| A Dental Pain Study Comparing The Analgesic Efficacy Of Ibuprofen/Caffeine (NCT02863575) | Pfizer | 2017-10-24 |
| Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors (NCT03330405) | Pfizer | 2017-10-19 |
| Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation (NCT03271047) | Pfizer | 2017-10-18 |
| First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects (NCT03309241) | Pfizer | 2017-10-17 |
| A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age (NCT03313050) | Pfizer | 2017-10-12 |
| Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age (NCT03313037) | Pfizer | 2017-10-10 |
| A Study Comparing the Amounts of 2 Different Forms of Tafamidis (PF06291826), Both With and Without Food, In the Blood (NCT03280173) | Pfizer | 2017-09-29 |
| 6-week Safety and PD Study in Adults With NAFLD (NCT03256526) | Pfizer | 2017-09-27 |
| A Study Comparing Amounts of 2 Different Forms of Tafamidis (PF-6291826) in the Blood (NCT03266705) | Pfizer | 2017-09-20 |
| A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis (NCT03260595) | Pfizer | 2017-09-13 |
| PK Study in Adult Healthy Volunteers to Assess QD Dosing With the Selected Age-appropriate MR Formulations (NCT03112148) | Pfizer | 2017-09-11 |
| A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) (NCT03289533) | Pfizer | 2017-09-08 |
| Bioavailability and Food Effect Study of Two Formulations of PF-06650833 (NCT03308110) | Pfizer | 2017-09-08 |
| Glasdegib Absolute Bioavailability Study (NCT03270878) | Pfizer | 2017-09-07 |
| Understanding Hemophilia A and B Drug Dosage Administration Patterns (NCT03248141) | Pfizer | 2017-09-01 |